Related Experiment Video

Updated: Dec 18, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.2K

"Monoclonal-Type" Plastic Antibodies for COVID-19 Treatment: What Is the Idea?

Francesco Puoci1,2

  • 1Health and Nutritional Sciences, Department of Pharmacy, University of Calabria, 87036 Rende (CS), Italy.

Journal of Functional Biomaterials
|June 21, 2020
PubMed

Insights

A novel coronavirus, 2019-nCoV, caused an outbreak in Wuhan, China in late 2019. This virus, now known as SARS-CoV-2, led to the COVID-19 pandemic.

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • An unprecedented outbreak of a novel coronavirus, 2019-nCoV, emerged in Wuhan, China.
  • The virus rapidly spread, leading to a global health crisis.

More Related Videos

Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium09:45

Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium

Published on: May 18, 2021

2.4K
Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.9K

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
16.9K